Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2001 1
2002 3
2003 3
2004 6
2005 5
2006 10
2007 3
2008 5
2009 6
2010 7
2011 4
2012 3
2013 2
2014 2
2015 7
2016 8
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26377301

70 results

Results by year

Filters applied: . Clear all
Page 1
PROLONGing remissions in patients with CLL.
Wiestner A. Wiestner A. Lancet Oncol. 2015 Oct;16(13):1282-4. doi: 10.1016/S1470-2045(15)00219-3. Epub 2015 Sep 13. Lancet Oncol. 2015. PMID: 26377301 No abstract available.
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study.
van Oers MH, Kuliczkowski K, Smolej L, Petrini M, Offner F, Grosicki S, Levin MD, Gupta I, Phillips J, Williams V, Manson S, Lisby S, Geisler C; PROLONG study investigators. van Oers MH, et al. Lancet Oncol. 2015 Oct;16(13):1370-9. doi: 10.1016/S1470-2045(15)00143-6. Epub 2015 Sep 13. Lancet Oncol. 2015. PMID: 26377300 Clinical Trial.
Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A, Faderl S, Keating MJ. Ferrajoli A, et al. Expert Rev Anticancer Ther. 2006 Sep;6(9):1231-8. doi: 10.1586/14737140.6.9.1231. Expert Rev Anticancer Ther. 2006. PMID: 17020457 Review.
Autologous activated macrophages (MAK) coated ex vivo with humanized anti-CD20 monoclonal antibodies can eradicate minimal residual disease in chronic lymphocytic leukaemia in clinical response.
Sutton L, Chaoui D, Cazin B, Azar N, Chokri M, Romet-Lemonne JL, Maloum K. Sutton L, et al. Br J Haematol. 2008 Sep;142(6):996-8. doi: 10.1111/j.1365-2141.2008.07272.x. Epub 2008 Jul 28. Br J Haematol. 2008. PMID: 18665839 Free article. Clinical Trial. No abstract available.
70 results